BIO LOGIC SYSTEMS CORP 4
4 · BIO LOGIC SYSTEMS CORP · Filed Jan 5, 2006
Insider Transaction Report
Form 4
HANLEY MICHAEL J
Corporate Controller
Transactions
- Exercise/Conversion
Common Stock
2006-01-04$3.37/sh+4,500$15,150→ 4,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-01-04−4,500→ 0 totalExercise: $3.37Exp: 2011-03-01→ Common Stock (4,500 underlying) - Exercise/Conversion
Common Stock
2006-01-04$3.11/sh+24,000$74,719→ 28,500 total - Exercise/Conversion
Common Stock
2006-01-04$2.17/sh+1,500$3,250→ 30,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-01-04−1,500→ 0 totalExercise: $2.17Exp: 2012-11-15→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2006-01-04$3.13/sh+3,000$9,380→ 33,000 total - Disposition to Issuer
Common Stock
2006-01-05−33,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-01-04−24,000→ 0 totalExercise: $3.11Exp: 2011-07-23→ Common Stock (24,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2006-01-04−3,000→ 0 totalExercise: $3.13Exp: 2013-09-23→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to the merger agreement among Issuer, Natus Medical Incorporated and Summer Acquisition Corporation, in which each share of common stock of the Issuer was exchanged for $8.77 in cash, without interest, on the effective date of the merger.
- [F2]These options became fully vested upon Issuer stockholder approval of the merger on January 4, 2006.